Human immunoglobulin (Zhejiang Haikang)
人免疫球蛋白（浙江海康）
Report date: 2022/03/01 16:03:14
Base Information
Drug NameHuman immunoglobulin (Zhejiang Haikang)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1999/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhejiang Haikang Biological Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesZhejiang Haikang Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A